the drug demonstrated significant activity in acute myelomonocytic leukemia with four responses among 19 patients , less activity in acute myelocytic leukemia with two responses among 44 patients , and little activity in acute lymphocytic leukemia with only one partial response among 12 patients .
C0023479
acute myelomonocytic leukemia
C0023467
acute myelocytic leukemia